Lembas Emerges from Stealth with Breakthrough Discovery in Natural GLP-1 for Weight Management PressReach · Jun 11, 2025
Opioid, Opiate, and Fentanyl Medical Treatment Without Medication Resembles Malpractice, Claims Addiction Treatment Authority In New Book PressReach · Jun 10, 2025
Koya Medical Opens New Dallas HQ to Power Next Phase of Growth in Vascular Health PressReach · Jun 10, 2025
Southwest General Partners with Notable to Close Care Gaps and Redefine Patient Access PressReach · Jun 10, 2025
Nuevocor Announces FDA Clearance of IND for NVC-001 for LMNA-Related Dilated Cardiomyopathy PressReach · Jun 10, 2025
Sanyou Biopharmaceuticals and Medicovestor, Inc. Forge Strategic Partnership to Develop First-in-Class Chemoimmunotherapy Antibody-Drug Conjugates PressReach · Jun 10, 2025
Microtech Announces the First U.S. Atrial Microsensor Implantations as Part of its FIH Study PressReach · Jun 9, 2025
Hansa Biopharma to Host Science Deep Dive Virtual Investor Event on Guillain-Barré Syndrome on June 16, 2025 PressReach · Jun 9, 2025
Over 4,400 Riders Embark on Ride to Conquer Cancer, Canada's Largest Athletic Fundraiser, Raising Over $20.61 Million for Life-Saving Research PressReach · Jun 8, 2025
Public Advisory - Health Canada warns consumers not to inhale nitrous oxide, also known as laughing gas, recreationally PressReach · Jun 7, 2025
